Detalles de la búsqueda
1.
Selection of Silica Type and Amount for Flowability Enhancements via Dry Coating: Contact Mechanics Based Predictive Approach.
Pharm Res
; 40(12): 2917-2933, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37468827
2.
Preparation of Free-Flowing Spray-Dried Amorphous Composites Using Neusilin®.
AAPS PharmSciTech
; 24(1): 51, 2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36703032
3.
Decoding Fine API Agglomeration as a Key Indicator of Powder Flowability and Dissolution: Impact of Particle Engineering.
Pharm Res
; 39(12): 3079-3098, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35698012
4.
Reduced Fine API Agglomeration After Dry Coating for Enhanced Blend Uniformity and Processability of Low Drug Loaded Blends.
Pharm Res
; 39(12): 3155-3174, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35882741
5.
A systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease.
J Vasc Surg
; 72(4): 1473-1486.e2, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360678
6.
iCAST Balloon-Expandable Covered Stent for Iliac Artery Lesions: 3-Year Results from the iCARUS Multicenter Study.
J Vasc Interv Radiol
; 30(6): 822-829.e4, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31031089
7.
Convective Drying Kinetics of Polymer Strip Films Loaded with a BCS Class II Drug.
AAPS PharmSciTech
; 20(2): 40, 2019 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610396
8.
Sustained Release of Poorly Water-Soluble Drug from Hydrophilic Polymeric Film Sandwiched Between Hydrophobic Layers.
AAPS PharmSciTech
; 19(6): 2572-2584, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29948990
9.
Crystal and Particle Engineering - An Indispensable Tool for Developing and Manufacturing Quality Pharmaceutical Products.
Pharm Res
; 39(12): 3041-3045, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36471027
10.
Preparation and characterization of fast dissolving pullulan films containing BCS class II drug nanoparticles for bioavailability enhancement.
Drug Dev Ind Pharm
; 42(7): 1073-85, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26567632
11.
An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
AAPS PharmSciTech
; 17(2): 389-99, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26182907
12.
Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.
Drug Dev Ind Pharm
; 41(10): 1617-31, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25347144
13.
Preparation of concentrated stable fenofibrate suspensions via liquid antisolvent precipitation.
Drug Dev Ind Pharm
; 40(12): 1693-703, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24102617
14.
Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
Drug Dev Ind Pharm
; 40(11): 1509-22, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23981202
15.
Facilitating direct compaction tableting of fine cohesive APIs using dry coated fine excipients: Effect of the excipient size and amount of coated silica.
Int J Pharm
; 660: 124359, 2024 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38901539
16.
Impact of dry coating lactose as a brittle excipient on multi-component blend processability.
Int J Pharm
; 653: 123921, 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382769
17.
Nine-month results of the REFORM study: a prospective, single-arm, multicenter clinical study of the safety and effectiveness of the Formula™ balloon-expandable stent for treatment of renal artery stenosis.
Catheter Cardiovasc Interv
; 82(2): 266-73, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22581488
18.
Impact of Silica Dry Coprocessing with API and Blend Mixing Time on Blend Flowability and Drug Content Uniformity.
J Pharm Sci
; 112(8): 2124-2136, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37230252
19.
Enhanced blend uniformity and flowability of low drug loaded fine API blends via dry coating: The effect of mixing time and excipient size.
Int J Pharm
; 635: 122722, 2023 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36796658
20.
Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
Catheter Cardiovasc Interv
; 80(5): 717-25, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22105829